RI

Ravi Ika

Active Director Director DIN 07163795
DIN 07163795 First appointment Jul 2015 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 2015
Shareholding value Locked Premium profile

About Ravi Ika

Ravi Ika has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Rxadvance Pbm India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07163795
Primary Designation Director
First Appointment 06 Jul 2015
Oldest Company Age 11 yrs

Current companies

Company Designation Appointment Founded Status
Rxadvance Pbm India Private Limited U72300UP2015FTC071836
Director 06 Jul 2015 2015 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rxadvance Pbm India Private Limited
Premium access

Shareholding and investment profile for Ravi Ika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Ika

Ravi Ika has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Rxadvance Pbm India Private Limited. Engaged in General Business. Contributes to corporate operations.

Ravi Ika is associated with 1 company as Director.

Ravi Ika has expertise in General Business.

Ravi Ika has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available